<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03460158</url>
  </required_header>
  <id_info>
    <org_study_id>827003</org_study_id>
    <nct_id>NCT03460158</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Facial Cosmetic Procedures</brief_title>
  <official_title>Prospective Evaluation of Minimally Invasive Facial Cosmetic Procedures Through Measured Volumetric Changes and Patient Reported Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Galderma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, trial to quantitatively and qualitatively compare the dermal fillers for the
      treatment of age related aesthetic changes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dermal fillers have been approved for the treatment of age related aesthetic changes,
      including facial volume loss, and attenuation of the static and dynamic rhytid. Despite
      widespread use of volumizing fillers there is little data quantifying the subjective benefit
      of these minimally invasive treatments from the patient perspective. Furthermore, there is
      little data comparing the subjective benefit with true objective volumetric results. Such
      data will provide much needed information for patient counselling and treatment optimization
      for patient perceived outcomes.

      This study is to determine the patient reported outcomes of three different dermal fillers
      and establish the volumetric changes over 90 days. Screening will be performed during the
      patient's office visit. Approximately 100 patients will be enrolled. Patients will
      participate up to 90 days (Day 1, 14 days, 28 days, and 90 days).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Satisfaction with validated FACE-Q survey</measure>
    <time_frame>upto 90 days</time_frame>
    <description>Patient satisfaction with validated survey FACE-Q</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlate patient satisfaction with volumetric measurements</measure>
    <time_frame>upto 90 days</time_frame>
    <description>regression analysis of satisfaction scores with changes in volumetric measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volumetric changes of treatment</measure>
    <time_frame>upto 90 days</time_frame>
    <description>3-dimensional photography to measure volumetric changes in each treatment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cosmetic Techniques</condition>
  <arm_group>
    <arm_group_label>Restylane-L®, Restylane-L® Lyft, and Restylane Silk®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyaluronic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Restylane-L®</intervention_name>
    <description>Restylane-L® for the indication for mid-to-deep dermal implantation for moderate to severe facial wrinkles and folds, such as nasolabial folds.</description>
    <arm_group_label>Restylane-L®, Restylane-L® Lyft, and Restylane Silk®</arm_group_label>
    <other_name>Hyaluronic acid gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Restylane-L® Lyft</intervention_name>
    <description>Restylane-L® Lyft is for the indication of implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds and malars (cheek/cheek bone area).</description>
    <arm_group_label>Restylane-L®, Restylane-L® Lyft, and Restylane Silk®</arm_group_label>
    <other_name>Hyaluronic acid gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Restylane Silk®</intervention_name>
    <description>Restylane Silk® is for the indication for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids in patients over the age of 21.</description>
    <arm_group_label>Restylane-L®, Restylane-L® Lyft, and Restylane Silk®</arm_group_label>
    <other_name>Hyaluronic acid gel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients 40 - 65 years of age

        Exclusion Criteria:

          -  Male patients

          -  Prior surgical facial rejuvenation procedures

          -  Facelift

          -  Neck lift

          -  Blepharoplasty

          -  Facial fat grafting

          -  Prior minimally invasive rejuvenation procedure ≤ 12 months

          -  Known contraindications to devices or drugs used in this study

          -  Facial paralysis

          -  Congenital facial asymmetry

          -  Pregnant women

          -  Patient actively taking blood thinners
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivona Percec, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robyn Broach, PhD</last_name>
    <phone>215-360-0640</phone>
    <email>robyn.broach@uphs.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robyn Broach, PhD</last_name>
      <email>robyn.broach@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Ivona Percec, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>facial filler</keyword>
  <keyword>Retylane</keyword>
  <keyword>aesthetic improvement</keyword>
  <keyword>volumizing fillers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

